The effects of TLR4 blocker on blood cell morphology, concentrations proinflammatory cytokines, and functional state of the liver and kidneys were studied in outbred male rats (n=60) after intravenous injection of 20 mg/kg LPS isolated from opportunistic Proteus mirabilis strain ATCC 51393. TLR4 blocker TLR4-IN-C34 was injected intravenously in a dose of 1 mg/kg/day over 3 days. Systemic inflammatory reaction induced by LPS was characterized by elevation of serum TNFα, IL-1β, IL-6, erythrocyte sedimentation rate, leukocytosis, and thrombocytosis. Increased activity of hepatocyte enzymes (ALT, alkaline phosphatase, and lactate dehydrogenase), retention of nitrogen metabolites (urea and creatinine), elevated content of protein oxidation products, and enhanced protein catabolism were also observed. Administration of TLR4 blocker reduced parameters of inflammatory reaction and prevented the development of hypercatabolic syndrome; endotoxicosis and kidney function indicators approached the normal levels.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10517-020-04981-9DOI Listing

Publication Analysis

Top Keywords

tlr4 blocker
12
systemic inflammatory
8
proteus mirabilis
8
inflammatory reaction
8
tlr4
4
tlr4 blockade
4
blockade indicators
4
indicators systemic
4
inflammatory response
4
response proteus
4

Similar Publications

Toll-like receptor 4 (TLR4) is an important mediator that activates bacterial inflammation through its signaling pathway. It binds lipopolysaccharide (LPS) in the presence of myeloid differentiation protein 2 (MD2) to dimerise the TLR4-MD2-LPS complex. The TLR4 mediated signaling pathway stimulates cytokine production in humans, initiating inflammatory responses.

View Article and Find Full Text PDF

Esophageal Cancer-Related Gene-4 Contributes to Lipopolysaccharide-Induced Ion Channel Dysfunction in hiPSC-Derived Cardiomyocytes.

J Inflamm Res

December 2024

Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Department of Cardiology, The Affiliated Hospital, Southwest Medical University, Luzhou, People's Republic of China.

Background And Purpose: Esophageal cancer-related gene-4 (ECRG4) participate in inflammation process and can interact with the innate immunity complex TLR4-MD2-CD14 on human granulocytes. In addition, ECRG4 participate in modulation of ion channel function and electrical activity of cardiomyocytes. However, the exact mechanism is unknown.

View Article and Find Full Text PDF

[Protective effect and mechanism of Zuogui Jiangtang Jieyu Formula on damage to hippocampal synaptic microenvironment in rats with diabetes-related depression based on microglia-neuron crosstalk signal CD300f/TLR4].

Zhongguo Zhong Yao Za Zhi

September 2024

Hunan Key Laboratory of Traditional Chinese Medicine Prevention and Treatment of Depressive Diseases Changsha 410208, China Science & Technology Innovation Center, Hunan University of Chinese Medicine Changsha 410208, China.

Article Synopsis
  • * Researchers induced a diabetes-related depression model in rats through diet, injections, and stress, then assessed behaviors, blood glucose, immune markers, and synaptic structures using various tests and analyses.
  • * Findings showed that the model rats exhibited increased immobility and reduced activity, alongside specific changes in immune and neurotransmitter levels in the hippocampus, indicating the potential effectiveness of the formula in modulating these negative effects.
View Article and Find Full Text PDF

Introduction: NLRP3, ASC, and procaspase-1 form the multiprotein complex known as the NLRP3 inflammasome. Following the priming of NLRP3 by TLR4 ligand, the activation of the NLRP3 inflammasome causes caspase-1 maturation, which results in the release of IL-1β. Calcium channel antagonists are commonly employed as antihypertensive medications and have anti-inflammatory properties through the inhibition of cytokine release, specifically IL-1β.

View Article and Find Full Text PDF

In vitro study on efficacy of SKF7, a Malaysian medicinal plant product against SARS-CoV-2.

BMC Complement Med Ther

September 2024

Herbal Medicine Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.

Background: In early 2020, COVID-19 pandemic has mobilized researchers in finding new remedies including repurposing of medicinal plant products focusing on direct-acting antiviral and host-directed therapies. In this study, we performed an in vitro investigation on the standardized Marantodes pumilum extract (SKF7) focusing on anti-SARS-CoV-2 and anti-inflammatory activities.

Methods: Anti-SARS-CoV-2 potential of the SKF7 was evaluated in SARS-CoV-2-infected Vero E6 cells and SARS-CoV-2-infected A549 cells by cytopathic effect-based assay and RT-qPCR, respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!